Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study
- PMID: 34363602
- PMCID: PMC8384983
- DOI: 10.1007/s13300-021-01126-7
Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study
Abstract
Introduction: Poor glycemic control is a serious challenge in successful diabetes management. Given the low adherence and compliance with HbA1c testing frequency and the corresponding delay in the appropriate medication adjustment, point-of-care testing (POCT) for HbA1c provides an opportunity for better control of diabetes and higher patient satisfaction. The data with this regard are limited in Saudi Arabia. Therefore, we aimed to assess the level of patient satisfaction associated with the POCT service implementation for HbA1c and evaluate the differences between the number of requested and conducted HbA1c tests before and after POCT implementation and its effect on glycemic control in Saudi clinical practice.
Methods: We conducted a single-center ambispective descriptive cohort study in Riyadh, Saudi Arabia. This study had two phases: the retrospective phase (January 2017 to December 2017) and the prospective phase (January 2018 to December 2018). Patient satisfaction was assessed using the patient satisfaction questionnaire short form (PSQ-18) and on-site HbA1c point-of-care testing (HbA1c-POCT) satisfaction questionnaire.
Results: This study included 75 patients with diabetes (37% type 1, 63% type 2) with a mean age of 44.35 (± 17.97) years. The adherence to physician recommendations for HbA1c testing frequency increased from 24% to 85% (before and after POCT implementation, respectively). High levels of satisfaction across seven dimensions of PSQ-18 (77-88%) were reported towards the provided healthcare service after POCT implementation. Furthermore, a high level of agreement on the statements of the on-site HbA1c-POCT satisfaction questionnaire was also observed. Finally, the mean HbA1c level has significantly improved after POCT implementation compared to the traditional HbA1c laboratory testing before POCT implementation [8.34 ± 0.67 and 8.06 ± 0.62, respectively, p < 0.001).
Conclusion: HbA1c testing at POCT improved adherence to recommendations for HbA1c testing frequency for better glycemic control and higher patient satisfaction. POCT reduces turnaround time, improves glycemic control, and facilitates the decision-making process. HbA1c measurement with POC devices is recommended to be implemented in diabetes treatment centers. All of the described benefits of POCT come together to make HbA1c testing the most common procedure for diabetes management at the point of care.
Keywords: Diabetes; HbA1c; POCT; PSQ-18; Point of care; Saudi Arabia.
© 2021. The Author(s).
Figures
Similar articles
-
Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study.Diabetes Ther. 2022 May;13(5):953-967. doi: 10.1007/s13300-022-01240-0. Epub 2022 Mar 20. Diabetes Ther. 2022. PMID: 35306640 Free PMC article.
-
The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.Rural Remote Health. 2005 Jul-Sep;5(3):371. Epub 2005 Jul 15. Rural Remote Health. 2005. PMID: 16026194
-
Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.Rural Remote Health. 2009 Jul-Sep;9(3):1189. Epub 2009 Aug 10. Rural Remote Health. 2009. PMID: 19689171 Clinical Trial.
-
Implementation of point-of-care testing in a pediatric healthcare setting.Crit Rev Clin Lab Sci. 2019 Jun;56(4):239-246. doi: 10.1080/10408363.2019.1590306. Epub 2019 Apr 11. Crit Rev Clin Lab Sci. 2019. PMID: 30973797 Review.
-
Impact of HbA1c Testing at Point of Care on Diabetes Management.J Diabetes Sci Technol. 2017 May;11(3):611-617. doi: 10.1177/1932296816678263. Epub 2016 Nov 27. J Diabetes Sci Technol. 2017. PMID: 27898388 Free PMC article. Review.
Cited by
-
Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study.Diabetes Ther. 2022 May;13(5):953-967. doi: 10.1007/s13300-022-01240-0. Epub 2022 Mar 20. Diabetes Ther. 2022. PMID: 35306640 Free PMC article.
-
Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.Adv Ther. 2023 Jun;40(6):2855-2868. doi: 10.1007/s12325-023-02508-y. Epub 2023 May 3. Adv Ther. 2023. PMID: 37133646
-
Facilitators and barriers of the implementation of point-of-care devices for cardiometabolic diseases: a scoping review.BMC Health Serv Res. 2023 Apr 28;23(1):412. doi: 10.1186/s12913-023-09419-2. BMC Health Serv Res. 2023. PMID: 37118750 Free PMC article.
-
Clinical Need for Point-of-Care Testing for Diabetes in Clinical and Laboratory Improvement Amendments-Waived Settings.Clin Diabetes. 2024 Oct 30;43(2):227-239. doi: 10.2337/cd24-0071. eCollection 2025 Spring. Clin Diabetes. 2024. PMID: 40290824 Free PMC article.
-
Comparison of Point-of-Care and Laboratory Glycated Hemoglobin A1c and Its Relationship to Time-in-Range and Glucose Variability: A Real-World Study.Cureus. 2023 Jan 5;15(1):e33416. doi: 10.7759/cureus.33416. eCollection 2023 Jan. Cureus. 2023. PMID: 36643084 Free PMC article.
References
-
- Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study. Diabetologia. 2019;62:408–417. doi: 10.1007/s00125-018-4763-3. - DOI - PubMed
-
- Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
LinkOut - more resources
Full Text Sources